TY - JOUR
AU - Uyoga, Sophie
AU - Adetifa, Ifedayo
AU - Karanja, Henry
AU - Nyagwange, James
AU - Tuju, James
AU - Wanjiku, Perpetual
AU - Aman, Rashid
AU - Mwangang, Mercy
AU - Amoth, Patrick
AU - Kasera, George
AU - Ng'ang'a, Wangari
AU - Rombo, Charles
AU - Yegon, Christine
AU - Kithi, Khamisi
AU - Odhiambo, Elizabeth
AU - Rotich, Thomas
AU - Orgut, Irene
AU - Kihara, Sammy
AU - Otiende, Mark
AU - Bottomley, Christian
AU - Mupe, Zonia
AU - Kagucia, Eunice
AU - Gallagher, Katherine E.
AU - Etyang, Anthony O.
AU - Voller, Shirine
AU - Gitonga, John N.
AU - Mugo, Daisy
AU - Agoti, Charles N.
AU - Otieno, Edward
AU - Ndwiga, Leonard
AU - Lambe, Teresa
AU - Wright, Daniel
AU - Barasa, Edwine
AU - Tsofa, Benjamin
AU - Bejon, Philip
AU - Ochola-Oyier, Lynette Isabella
AU - Agweyu, Ambrose
AU - Scott, J.A.G.
AU - Warimwe, George
PY - 2020
DA - November
TI - Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
JO - Science
EP - 82
VL - 371
IS - 6524
DO - https://doi.org/10.1126/science.abe1916
AB - The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, and an overwhelming number of cases and deaths were expected, but by 31 July 2020, there were only 20,636 cases and 341 deaths. However, the extent of SARS-CoV-2 exposure in the community remains unknown. We determined the prevalence of anti-SARS-CoV-2 immunoglobulin G among blood donors in Kenya in April-June 2020. Crude seroprevalence was 5.6% (174 of 3098). Population-weighted, test-performance-adjusted national seroprevalence was 4.3% (95% confidence interval, 2.9 to 5.8%) and was highest in urban counties Mombasa (8.0%), Nairobi (7.3%), and Kisumu (5.5%). SARS-CoV-2 exposure is more extensive than indicated by case-based surveillance, and these results will help guide the pandemic response in Kenya and across Africa.
PB - American Association for the Advancement of Science
UR - https://eprints.gla.ac.uk/325339/
KW - Coronavirus (COVID-19)
ER